Work

Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial

Year: 2016

Type: article

Source: The Lancet Diabetes & Endocrinology

DOI: 10.1016/s2213-8587(15)00469-6

Authors: Hiddo J L Heerspink, Frederik Persson, Barry M Brenner, Nish Chaturvedi, Patrick Brunel, John J McMurray, Akshay S Desai, Scott D Solomon, Marc A Pfeffer, Hans-Henrik Parving, Dick de Zeeuw

Institutions: University Medical Center Groningen, University of Groningen, Brigham and Women's Hospital, Harvard University, University College London, Novartis (Switzerland), University of Glasgow, University of Copenhagen, Rigshospitalet

Language: English

Topic: Chronic Kidney Disease and Diabetes

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Novartis

OpenAlex ID: W2252435576

FWCI: 7.028

Cites: 33

Cited by: 49

Related to: 10